You are here

  • Home
  • Archive
  • Volume 16, Issue 1
  • Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness

https://doi.org/10.1136/ebm1127

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests MJB has received lecture or consultant fees from Pfizer, GSK, Xenoport, UCB, Cephalon, Sepracor, Boehringer-Ingelheim, Sanofi-Aventis and Schering.